Dawn D. Parker - Concepedia

Author

Dawn D. Parker

Bristol-Myers Squibb (United States)

Also Known As

D. Parker, David Parker, Dawn D. Parker, Dawn DiGiugno Parker, Dawn Parker, Devon Parker, Parker, Dawn, Parker, Dawn D.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (India)Biocon (India)Wellcome Trust GlaxoSmithKline (United States)

About

Dawn D. Parker is an author at Bristol-Myers Squibb (United States) specializing in medicine, hiv, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	752
2	Natural Sciences	12	12	416
3	Biochemistry	9	9	337
4	Biomolecular Engineering	3	3	115
5	Engineering	1	1	47

Dawn D. Parker

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6 Vasker Bhattacherjee, L. E. Prescott, Ian Pike, Journal of General Virology Type-specific AntibodyViral DiagnosticsNs-4 PeptidesImmunologyPathology	1995	137
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects Tao Wang, Zhiwei Yin, Zhongxing Zhang, Journal of Medicinal Chemistry Organic ChemistryHiv-1-infected SubjectsPharmacotherapyAntiviral DrugAzaindole Leads	2009	98
Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase Robert G. Gentles, Min Ding, John A. Bender, Journal of Medicinal Chemistry	2014	98
Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir Makonen Belema, Van N. Nguyen, Carol Bachand, Journal of Medicinal Chemistry	2014	87
Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity Alicia Regueiro‐Ren, Zheng Liu, Yan Chen, ACS Medicinal Chemistry Letters Medicinal ChemistryTranslational MedicineGood Oral ExposureMedicineHuman Retrovirus	2016	54
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 12. Structure–Activity Relationships Associated with 4-Fluoro-6-azaindole Derivatives Leading to the Identification of 1-(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-585248) Alicia Regueiro‐Ren, Qiufen Xue, Jacob J. Swidorski, Journal of Medicinal Chemistry Vitro PotencyGood PotencyAzaindole CoreAntiviral DrugChemical Biology	2013	50
Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives Tao Wang, John F. Kadow, Zhongxing Zhang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntiviral CompoundMedicineAntiviral Drug DevelopmentAntiviral Therapy	2009	49
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)-2-oxoethanone (BMS-488043) John F. Kadow, Yasutsugu Ueda, Nicholas A. Meanwell, Journal of Medicinal Chemistry	2012	49
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors B. Narasimhulu Naidu, Margaret E. Sorenson, Manoj Patel, Bioorganic & Medicinal Chemistry Letters EngineeringMedicineDrug DiscoveryAntiviral Drug DevelopmentOrganic Chemistry	2014	47
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir Tao Wang, Yasu Ueda, Zhongxing Zhang, Journal of Medicinal Chemistry	2018	47

Page 1